CD40 ligand gene and Kawasaki disease

被引:44
|
作者
Onouchi, Y
Onoue, S
Tamari, M
Wakui, K
Fukushima, Y
Yashiro, M
Nakamura, Y
Yanagawa, H
Kishi, F
Ouchi, K
Terai, M
Hamamoto, K
Kudo, F
Aotsuka, H
Sato, Y
Nariai, A
Kaburagi, Y
Miura, M
Saji, T
Kawasaki, T
Nakamura, Y
Hata, A
机构
[1] RIKEN, SNP Res Ctr, Lab Gastrointestinal Dis, Kanagawa 2300045, Japan
[2] RIKEN, SNP Res Ctr, Lab Genet Allerg Dis, Kanagawa 2300045, Japan
[3] Shinshu Univ, Sch Med, Dept Prevent Med, Matsumoto, Nagano, Japan
[4] Jichi Med Sch, Dept Publ Hlth, Minami Kawachi, Tochigi, Japan
[5] Saitama Prefectural Univ, Urawa, Saitama, Japan
[6] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Dev Med, Div Mol Genet, Kagoshima 890, Japan
[7] Kawasaki Med Sch, Dept Pediat, Kawasaki, Kanagawa, Japan
[8] Chiba Univ, Grad Sch Med, Dept Pediat, Chiba, Japan
[9] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka, Japan
[10] Chiba Childrens Hosp, Dept Otorhinolaryngol, Chiba, Japan
[11] Chiba Childrens Hosp, Dept Cardiol, Chiba, Japan
[12] Fuji Heavy Ind Co Ltd, Hlth Insurance Soc Gen Ota Hosp, Dept Pediat, Fuji, Shizuoka, Japan
[13] Yokohama Minami Kyosai Hosp, Dept Pediat, Yokohama, Kanagawa, Japan
[14] Seirei Yokohama Hosp, Dept Pediat, Yokohama, Kanagawa, Japan
[15] Keio Univ, Sch Med, Dept Pediat, Tokyo 108, Japan
[16] Toho Univ, Sch Med, Dept Pediat 1, Funabashi, Chiba, Japan
[17] Japan Kawasaki Dis Res Ctr, Kawasaki, Kanagawa, Japan
[18] Univ Tokyo, Inst Med Sci, Human Genome Ctr, Mol Med Lab, Tokyo, Japan
[19] Chiba Univ, Grad Sch Med, Dept Publ Hlth, Chiba, Japan
关键词
Kawasaki disease; coronary artery lesion; CD40L; SNPs;
D O I
10.1038/sj.ejhg.5201266
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Kawasaki disease (KD) is an acute systemic vasculitis syndrome of infants and young children. Although its etiology is largely unknown, epidemiological findings suggest that genetic factors play a role in the pathogenesis of KD. To identify genetic factors, affected sib-pair analysis has been performed. One of the identified peaks was located on the Xq26 region. A recent report of elevated expression of CD40 ligand (CD40L), which maps to Xq26, during the acute-phase KD, and its relationship to the development of coronary artery lesions (CAL) prompted us to screen for polymorphism of CD40L and to study the association of the gene to KD. A newly identified SNP in intron 4 (IVS4+121 A>G) is marginally over-represented in KD patients as compared to controls (109/602, 18.1 vs 111/737, 15.1%). When male KD patients with CAL were analyzed as a patient group, the SNP was significantly more frequent than in controls (15/58, 25.9%, vs 111/737, 15.1%, OR 2.0, 95% CI 1.07-3.66; P=0.030). Interestingly, this variation was extremely rare in a control Caucasian population (1/145, 0.7%). Our results suggest a role of CD40L in the pathogenesis of CAL and might explain the excess of males affected with KD.
引用
收藏
页码:1062 / 1068
页数:7
相关论文
共 50 条
  • [31] Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome
    Seyama, K
    Nonoyama, S
    Gangsaas, I
    Hollenbaugh, D
    Pabst, HF
    Aruffo, A
    Ochs, HD
    BLOOD, 1998, 92 (07) : 2421 - 2434
  • [32] Dependence of murine obstructive airway disease on CD40 ligand
    Rumbley, CA
    Silver, SJ
    Phillips, SM
    TRANSPLANTATION, 2001, 72 (10) : 1616 - 1625
  • [33] The role of osteopontin in the induction of the CD40 ligand in Graves' disease
    Qi, Yicheng
    Li, Xiaoli
    Ma, Xinran
    Xu, Lingyan
    Zhang, Xiaofang
    Jiang, Xiaohua
    Hong, Jie
    Cui, Bin
    Ning, Guang
    Wang, Shu
    CLINICAL ENDOCRINOLOGY, 2014, 80 (01) : 128 - 134
  • [34] The Relation between CD40 Ligand and Coronary Artery Disease
    Balta, Sevket
    Ozturk, Cengiz
    CARDIOLOGY, 2015, 131 (02) : 107 - 108
  • [35] Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia
    Garlichs, CD
    John, S
    Schmeisser, A
    Eskafi, S
    Stumpf, C
    Karl, M
    Goppelt-Struebe, M
    Schmieder, R
    Daniel, WG
    CIRCULATION, 2001, 104 (20) : 2395 - 2400
  • [36] CD40 ligand in pathogenesis of autoimmune ovarian disease of day 3-thymectomized mice: Implication for CD40 ligand antibody therapy
    Sharp, C
    Thompson, C
    Samy, ET
    Noelle, R
    Tung, KSK
    JOURNAL OF IMMUNOLOGY, 2003, 170 (04): : 1667 - 1674
  • [37] THE CD40 ANTIGEN AND ITS LIGAND
    BANCHEREAU, J
    BAZAN, F
    BLANCHARD, D
    BRIERE, F
    GALIZZI, JP
    VANKOOTEN, C
    LIU, YJ
    ROUSSET, F
    SAELAND, S
    ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 : 881 - 922
  • [38] CD40 and its ligand in autoimmunity
    Noelle, RJ
    Mackey, M
    Foy, T
    Buhlmann, J
    Burns, C
    B LYMPHOCYTES AND AUTOIMMUNITY, 1997, 815 : 384 - 391
  • [39] MICE DEFICIENT FOR THE CD40 LIGAND
    XU, JC
    FOY, TM
    LAMAN, JD
    ELLIOTT, EA
    DUNN, JJ
    WALDSCHMIDT, TJ
    ELSEMORE, J
    NOELLE, RJ
    FLAVELL, RA
    IMMUNITY, 1994, 1 (05) : 423 - 431
  • [40] SOLUBLE CD40 LIGAND IN DEMENTIA
    Giunta, B.
    Figueroa, K. P.
    Town, T.
    Tan, J.
    DRUGS OF THE FUTURE, 2009, 34 (04) : 333 - 339